Brian Armstrong

I would agree with the Turing test comparison where we probably will go past it and people won't, nobody will react.

I think that's probably likely.

I don't think it'll happen this year or next year, but 2033 could potentially happen.

I mean, it's like the FDA approval part is the slow part, right?

The AI part is going really fast.

I will fly anywhere for the treatment.

It's not one of the ones we've targeted yet, but yeah, I think it's on the list somewhere.

We're going to have to get to all the major tissues at some point.

Yeah.

Yeah.

I mean, that would pair nicely with the GOP ones, right?

For sure.

Yeah, well, on the idea of going into biotech, I mean, there's definitely some Elon inspiration there, which is like we're living through a golden age of software where fortunes are being made.

And so I think these hard tech problems deserve more capital.

And, you know, it's almost like SpaceX probably would not have existed unless a wealthy individual like Elon, who had had an exit, had at least some of his own capital to go try and do it.

Same thing with Tesla, right?

So

Venture capital sometimes doesn't get you all the way there.

It's almost like to do these real moonshots, you have to like find someone who made a billion dollars in software and then go found, step two, go found the moonshots.

But I hope that that's not the case forever.